Poorly differentiated ovarian Sertoli-Leydig cell tumor with heterologous rhabdomyosarcomatous elements associated with elevated serum alpha-fetoprotein level: a case report and review of the literature
1Department of Gynecology, Affiliated Hospital of Medical School, Ningbo University
2Diagnostic Pathology Center, Ningbo city (China)
DOI: 10.31083/j.ejgo.2020.01.4806 Vol.41,Issue 1,February 2020 pp.138-141
Published: 15 February 2020
Ovarian Sertoli-Leydig cell tumors (SLCTs) are uncommon sex cord–stromal tumors. Moreover, SLCTs with heterologous mesenchymal elements are extremely rare and usually associated with poor differentiation and prognosis. Herein, the authors describe a case of SLCT involving the right ovary in a 16-year-old girl who presented with acute lower abdominal pain and fever. Serum investigation demonstrated abnormally elevated level of alpha-fetoprotein (AFP), slightly elevation of testosterone, and CA125 concentration. Right salpingo-oopherectomy was performed due to ovarian tumor torsion and then histopathological analysis revealed a poorly differentiated Sertoli-Leydig cell tumor with heterologous rhabdomyosarcomatous elements. A brief review of the literature was conducted to explore the management options for patients with SLCTs and the prognosis.
Ovary; Sertoli-Leydig cell tumors; Sex cord-stromal tumors; Rhabdomyosarcoma; Alpha fetoprotein.
Z. Hao,S. Yang,X. Deng. Poorly differentiated ovarian Sertoli-Leydig cell tumor with heterologous rhabdomyosarcomatous elements associated with elevated serum alpha-fetoprotein level: a case report and review of the literature. European Journal of Gynaecological Oncology. 2020. 41(1);138-141.
 Gui T., Cao D., Shen K., Yang J., Zhang Y., Yu Q., et al.: “A clinicopathological analysis of 40 cases of ovarian Sertoli-Leydig cell tumors”. Gynecol. Oncol., 2012, 127, 384.
 Young R.H., Scully R.E.: “Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases”. Am. J. Surg. Pathol.,1985, 9, 543.
 Watanabe T., Yamada H., Morimura Y., Abe M., Motoyama T., Sato A.: “Ovarian Sertoli-Leydig cell tumor with heterologous gastrointestinal epithelium as a source of alpha-fetoprotein: a case report”. J. Obstet. Gynaecol. Res., 2008, 34, 418.
 Schultz K.A., Schneider D.T., Pashankar F., Ross J., Frazier L.: “Management of ovarian and testicular sex cord-stromal tumors in children and adolescents”. J. Pediatr. Hematol. Oncol., 2012, 34, S55.
 Takeda A., Watanabe K., Hayashi S., Imoto S., Nakamura H.: “Gynandroblastoma with a Juvenile Granulosa Cell Component in an Adolescent: Case Report and Literature Review”. J. Pediatr. Adolesc. Gynecol., 2017, 30, 251.
 Oliva E, Carcangiu M, Carinelli S, Ip P, Loening T, Longacre T, et al.:”Tumours of the uterine corpus: mesenchymal tumours”. WHO classification of tumours of female reproductive organs. 4 th ed.,2014.
 Young R.H.: “Sertoli-Leydig cell tumors of the ovary: review with emphasis on historical aspects and unusual variants”. Int. J. Gynecol. Pathol.,1993, 12, 141.
 Goldblum J.R.: “An approach to pleomorphic sarcomas: can we subclassify, and does it matter?”. Mod. Pathol.,2014, 27, S39.
 Cessna M.H., Zhou H., Perkins S.L., Tripp S.R., Layfield L., Daines C., et al.: “Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics”. Am. J. Surg. Pathol., 2001, 25, 1150.
 Talerman A., Roth L.M.: “Recent advances in the pathology and classification of gonadal neoplasms composed of germ cells and sex cord derivatives”. Int. J. Gynecol. Pathol., 2007, 26, 313.
 Friedman C., Fenster T.: “Laparoscopic Treatment of Mixed Malignant Ovarian Germ Cell Tumor in a 16-Year-Old Female Adolescent”. J. Pediatr. Adolesc. Gynecol., 2016, 29, e91.
 de la Motte Rouge T., Pautier P., Genestie C., Rey A., Gouy S., Leary A., et al.:”Prognostic significance of an early decline in serum alphafetoprotein during chemotherapy for ovarian yolk sac tumors”. Gynecol. Oncol., 2016, 142, 452.
 Motoyama I., Watanabe H., Gotoh A., Takeuchi S., Tanabe N., Nashimoto I.: “Ovarian Sertoli-Leydig cell tumor with elevated serum alpha-fetoprotein”. Cancer, 1989, 63, 2047.
 Horta M., Cunha T.M., Marques R.C., Felix A.: “Ovarian SertoliLeydig cell tumor with heterologous elements of gastrointestinal type associated with elevated serum alpha-fetoprotein level: an unusual case and literature review”. J. Radiol. Case Rep., 2014, 8, 30.
 Shu H., Yang X., Gao A.F.: “Ovarian Sertoli-Leydig cell tumor in a 9-month-old infant with special histologic pattern”. Fetal Pediatr. Pathol., 2012, 31, 388.
 Plastini T., Staddon A.: “Sertoli-Leydig Cell Tumor with Concurrent Rhabdomyosarcoma: Three Case Reports and a Review of the Literature”. Case Rep. Med., 2017, 2017, 4587296.
 Zaloudek C., Norris H.J.: “Sertoli-Leydig tumors of the ovary. A clinicopathologic study of 64 intermediate and poorly differentiated neoplasms”. Am. J. Surg. Pathol.,1984 ,8, 405.
 Burnik Papler T., Frkovic Grazio S., Kobal B.: “Sertoli - Leydig cell tumor with retiform areas and overgrowth of rhabdomyosarcomatous elements: case report and literature review”. J. Ovarian Res., 2016, 9, 46.
 Guerard M.J., Ferenczy A., Arguelles M.A.:”Ovarian Sertoli-Leydig cell tumor with rhabdomyosarcoma: an ultrastructural study”. Ultrastruct Pathol.,1982, 3, 347.
 Grove A., Vestergaard V.: “Ovarian Sertoli-Leydig cell tumor of intermediate grade with heterologous elements of rhabdomyosarcoma. A case report and a review of the literature”. Ann. Diagn. Pathol., 2006, 10, 288.
 Kostopoulou E., Talerman A.: “Ovarian Sertoli-Leydig cell tumor of intermediate differentiation with immature skeletal muscle heterologous elements”. Acta Obstet. Gynecol. Scand., 2003, 82, 197.
 Prat J., Young R.H., Scully R.E. “Ovarian Sertoli-Leydig cell tumors with heterologous elements. II. Cartilage and skeletal muscle: a clinicopathologic analysis of twelve cases”. Cancer, 1982, 50, 2465.
 Sigismondi C., Gadducci A., Lorusso D., Candiani M., Breda E., Raspagliesi F., et al.: “Ovarian Sertoli-Leydig cell tumors. a retrospective MITO study”. Gynecol. Oncol., 2012, 125, 673.
 Pautier P., Gutierrez-Bonnaire M., Rey A., Sillet-Bach I., Chevreau C., Kerbrat P., et al.: “Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors”. Int. J. Gynecol. Cancer, 2008, 18, 446.
 Gershenson D.M., Morris M., Burke T.W., Levenback C., Matthews C.M., Wharton J.T.: “Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin”. Obstet. Gynecol.,1996, 87, 527.
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.
Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.
JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.
Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.
BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.